Lam Research logo

LRCX - Lam Research News Story

$601.14 -20.7  -3.3%

Last Trade - 8:06pm

Sector
Technology
Size
Large Cap
Market Cap £64.93bn
Enterprise Value £65.21bn
Revenue £11.68bn
Position in Universe 149th / 7414

Lam Research Appoints Jyoti Mehra to Board of Directors

Tue 16th November, 2021 9:15pm
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211116:nGNXnM62r&default-theme=true


FREMONT, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Lam Research Corporation
(NASDAQ: LRCX) today announced Jyoti Mehra has joined its board of directors,
effective November 9th.

A renowned expert in human capital, Mehra specializes in devising strategies
that promote a diverse and inclusive workforce, elevate team performance, and
attract, develop, and retain employee talent. She currently serves as
executive vice president of human resources at Gilead Sciences, Inc., where
she is responsible for leading the company’s people strategy and building an
inclusive, collaborative culture.

Prior to joining Gilead in 2017, Mehra held a senior leadership position with
Novartis Pharmaceuticals Corporation and worked for Novartis affiliates in the
United States, Europe, and China, bringing broad international perspectives to
her work. She also has extensive experience in cultivating business
partnerships and organizational design.
 
Mehra brings invaluable expertise to Lam Research at a time when the
company is rapidly scaling its global workforce and operations to
deliver the advanced chipmaking technologies that are helping to
propel the semiconductor industry – and the world – forward.

“As global demand for semiconductors continues to surge, the need to
cultivate a robust talent pipeline has never been more crucial,” said
Abhijit Talwalkar, chairman of the board at Lam Research. “Jyoti Mehra is a
widely respected and visionary human resources leader – we are incredibly
proud to welcome her to our board of directors. She brings a wealth of
experience and a unique perspective to Lam Research that will help us in
realizing our mission to cultivate and grow an inclusive, diverse and
equitable workforce as we accelerate business growth.”

About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of innovative
wafer fabrication equipment and services to the semiconductor industry.
Lam’s equipment and services allow customers to build smaller and better
performing devices. In fact, today, nearly every advanced chip is built with
Lam technology. We combine superior systems engineering, technology
leadership, and a strong values-based culture, with an unwavering commitment
to our customers. Lam Research is a FORTUNE 500® company headquartered in
Fremont, California, with operations around the globe. Learn more at
www.lamresearch.com.

Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are
forward-looking statements and are subject to the safe harbor provisions
created by the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements relate to, but are not limited to: the growth of
our workforce, operations and business; our ability to deliver advanced
technologies and the significance of those technologies to the semiconductor
industry; and demand for semiconductors. Some factors that may affect these
forward-looking statements include: supply chain disruptions or manufacturing
capacity constraints may limit our ability to manufacture and sell our
products; trade regulations, export controls, trade disputes, and other
geopolitical tensions may inhibit our ability to sell our products; business,
political and/or regulatory conditions in the consumer electronics industry,
the semiconductor industry and the overall economy may deteriorate or change;
the actions of our customers and competitors may be inconsistent with our
expectations; the severity, magnitude and duration of the COVID–19 pandemic
(and the related governmental, public health, business and community responses
to it), and their impacts on our business, results of operations and financial
condition, are evolving and are highly uncertain and unpredictable; and
widespread outbreaks of illness may impact our operations and revenue in
affected areas; as well as the other risks and uncertainties that are
described in the documents filed or furnished by us with the Securities and
Exchange Commission, including specifically the Risk Factors described in our
annual report on Form 10-K for the fiscal year ended June 27, 2021 and our
quarterly report on Form 10-Q for the fiscal quarter ended September 26, 2021.
These uncertainties and changes could materially affect the forward-looking
statements and cause actual results to vary from expectations in a material
way. The Company undertakes no obligation to update the information or
statements made in this release.



Company Contacts

Hope Nicora
Corporate Communications
(831) 227-3660
publicrelations@lamresearch.com

Ram Ganesh
Investor Relations
(510) 572-1615
investor.relations@lamresearch.com

(https://www.globenewswire.com/NewsRoom/AttachmentNg/24a5c3f8-2a56-4aa2-9b6b-c87e89d221de)



GlobeNewswire, Inc. 2021
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.